Brief: Quantum Genomics receives FDA clearance of IND application for QGC001

Quantum Genomics SA

05/09/2017 17:01

Sept 5 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA : 
    * QUANTUM GENOMICS RECEIVES FDA CLEARANCE OF IND APPLICATION 
FOR QGC001  
    * COMPANY TO LAUNCH NEW-HOPE, A TARGETED PHASE II CLINICAL 
TRIAL IN HYPERTENSION IN THE U.S.  
    * CLINICAL STUDY TO RECRUIT 250 HYPERTENSIVE AND OVERWEIGHT 
PATIENTS 
    * FIRST PATIENT IS EXPECTED TO BE ENROLLED IN Q4 OF 2017 
    * PRELIMINARY RESULTS ARE EXPECTED IN FIRST HALF OF 2019 
 
Source text for Eikon:  ID:nACT49983  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))